Skip to main content
. 2021 May 10;9(5):e001942. doi: 10.1136/jitc-2020-001942

Figure 2.

Figure 2

Construction and assessment of the copy number variation (CNV) risk score for hepatobiliary cancers. (A, E) The CNV risk scores of the patients in the discovery and validation cohorts sorted in ascending order. (B, F) Distributions of vital status for each patient according to the CNV risk score levels. (C, G) The copy number Z-scores and level of CNV risk scores of CALR, NR4A3, IDH2, IGF1R, ETV6, STAT3, NF2 and CTCF are shown in the heatmap. (D, H) The area under the curve (AUC) of the time-dependent receiver operating characteristic (ROC) curve was 0.881 in the discovery cohort and 0.907 in the validation cohort for the CNV risk score.